Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases

Citation
Ahj. Danser et H. Schunkert, Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases, EUR J PHARM, 410(2-3), 2000, pp. 303-316
Citations number
83
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
410
Issue
2-3
Year of publication
2000
Pages
303 - 316
Database
ISI
SICI code
0014-2999(200012)410:2-3<303:RSGPPM>2.0.ZU;2-9
Abstract
Since the first description of the angiotensin-converting enzyme insertion/ deletion polymorphism more than a decade ago, many hundreds of investigatio ns have reported associations between this polymorphism and cardiovascular diseases. Subsequently, similar studies were performed in relationship with several other renin-angiotensin system gene polymorphisms, most notably th e angiotensinogen M235T polymorphism and the angiotensin AT, receptor A1166 C polymorphism. Surprisingly however, especially in view of the many contra dictory results that have been obtained, very little attention has been pai d to the mechanism(s) that may link these genetic variants and respective d iseases. Here, we review the limited evidence that is currently available o n the functional consequences (including compensatory mechanisms) of the ab ove three renin-angiotensin system gene polymorphisms, in order to provide an explanation for the reported associations (or lack thereof) between thes e polymorphisms and cardiovascular diseases. (C) 2000 Elsevier Science B.V. All rights reserved.